Johnny Shen, MD
Family Medicine · Denver, CONPI 1881988541
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (38.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Genentech USA, Inc. accounts for 70.6% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $3,655 and has fallen 99.4% since, to $20 in 2025. Among family medicine clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 68 payments — averaging $74.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$4K
- Biohaven Pharmaceuticals, Inc.$487
- Kowa Pharmaceuticals America, Inc.$399
- Biohaven Pharmaceutical Holding Company Ltd.$321
- Pfizer$124
- Gilead$124
- plus $34 from 2 others
Across 21 payments — averaging $8423.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Quidel Corporation$92K
- Abbott$52K
- Rapid Pathogen Screening, Inc.$28K
- Roche Molecular Systems, Inc.$6K
What the payments were for
- Speaking & faculty fees$1,90037%
- Travel & lodging$1,24024%
- Food & beverage$1,92938%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 11 | $3,580 |
| Biohaven Pharmaceuticals, Inc. | 8 | $487 |
| Kowa Pharmaceuticals America, Inc. | 30 | $399 |
| Biohaven Pharmaceutical Holding Company Ltd. | 10 | $321 |
| Pfizer | 6 | $124 |
| Gilead | 1 | $124 |
| Exeltis, USA Inc. | 1 | $19 |
| Merck | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xofluza$3,457
- NURTEC ODT$498
- Descovy$124
How this compares
$5,069 in reported general payments places this provider in the 90th percentile of 2,079 family medicine providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 33 | $278 |
| Methylprednisolone | 38 | $273 |
| Doxycycline Hyclate | 15 | $165 |
| Cephalexin | 20 | $163 |
| Azithromycin | 15 | $67 |
| Prednisone | 29 | $58 |
| PaxlovidNirmatrelvir/Ritonavir | 15 | $0 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPaxlovid | $124 | $015 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,079 family medicine providers in Colorado.
Other family medicine in Denver
- Ethan LazarusDenver$688K
- Mark DeutchmanDenver$258K
- Mia ScottDenver$53K
- Flory KreutterDenver$13K
- Khoi NguyenDenver$13K
- Michael de NardisLarkspur$335K
- Matthew YoungColorado Springs$270K
- Kari UusinarkausWoodland Park$254K
- Michael MeekerUsaf Academy$174K
- Carolynn Francavilla BrownLakewood$174K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.